Labiotech.eu - Europe's leading Biotech News Website
WEB1 day ago · Delve into the psychedelic-assisted therapy market and investors’ sentiment after the FDA’s decision about Lykos’ therapy. Labiotech.eu covers the global biotech industry, read by 150,000+ monthly visitors. Hope you'll enjoy our Biotech News!
Needle-free diabetes care: 7 devices that painlessly monitor blood …
WEBOct 7, 2022 · D-Base is a shoebox-sized blood sugar monitor developed by the German firm DiaMonTech. The device measures blood sugar levels by beaming an infrared laser through the skin of a finger and causing glucose in the skin to convert the light to heat. The machine then calculates glucose levels based on the increase of heat in the skin.
Next-Generation mRNA Vaccine Technology Unveiled in Series A …
WEBJun 1, 2021 · The oversubscribed Series A round, whose original target was €20M, was supported by Belgian Family Offices. The idea of messenger RNA (mRNA) vaccines is to deliver genetic instructions to our cells to create proteins that then train the immune system against a pathogen, such as a virus. The saRNA technology builds on this concept, allowing ...
The twelve hottest biotech companies in the Boston area
WEBMar 12, 2024 · The Boston region has sprouted many influential public biotech companies. One of the most successful in recent years was Moderna, a giant messenger RNA (mRNA) specialist incubated by the VC firm Flagship Pioneering. Moderna would go on to produce one of the first COVID-19 vaccines in 2020. Another prestigious name, Vertex Pharmaceuticals, one ...
An Update on What’s New in the French Biotech Industry
WEBJan 17, 2018 · Which diseases are French biotechs targeting? The top 3 areas from 2015 – oncology, infectious diseases, and neurology – have kept their places at the top in 2017. Oncology now commands the attention of 30% of the biotechs that took part in the study – a 7% increase vs 2015 – while infectious diseases and …
Equity Crowdfunding for Biotech Startups: Does It Work?
WEBMar 31, 2021 · Bionure, a Spanish biotech company developing a drug for multiple sclerosis, raised €1.3M in equity crowdfunding through Capital Cell in 2019. According to Laurent, the round complemented money raised through venture capital and grants and allowed the company to start a phase II trial. Just having the …
Novago Raises €8.8M to Progress Regenerative Stroke Treatment
WEBMarch 4, 2019 - Updated on June 24, 2022. 3 minutes. The Swiss company NovaGo has raised €8.8M (CHF 10M) in Series A funding to develop one of the first therapies to help the nervous system regenerate after a stroke. Novago develops antibodies that inhibit Nogo-A, a key molecule that stops nerve cells from growing new connections in the adult ...
The 20 European Biotech Companies to Watch in 2022
WEBJan 5, 2022 · 15. Oryzon Genomics. Oryzon Genomics develops epigenetic drugs for the treatment of neurological diseases and cancer. In 2022, the company is expecting data readouts of several ongoing clinical trials targeting a range of conditions including acute myeloid leukemia, borderline personality disorder, and schizophrenia.
10 neuroscience biotech companies you should know about
WEBAug 15, 2024 · Developing treatments for neurological diseases presents a huge challenge for neuroscience companies within the biotech industry. The central nervous system (CNS) is extremely complex and many neurological diseases can be difficult to treat due to the limited regenerative capacity of the CNS, and the fact that the blood-brain barrier – a specialized system of cells that blocks harmful ...
CRISPR-Cas9: The Gene Editing Tool Changing the World
WEBNov 3, 2021 · CRISPR -Cas9 is one of the biggest discoveries of the 21st century. Since it was developed in 2012, this gene-editing tool has revolutionized biology research, making it easier to study disease and faster to discover drugs. The technology is also significantly impacting the development of crops, foods, and industrial fermentation processes.